While some studied describe Rituximab role in treating chronic immune mediated neuropathy including chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), anti-myelin-associated glycoprotein (MAG) neuropathy, and autoimmune nodopath [1, 9]other smaller case series suggested possible worsening of Anti-MAG neuropathy [10]. The gene discussed is MAG; the disease is chronic inflammatory demyelinating polyradiculoneuropathy.